4 Jobs bei Baxter-Deutschland

(Senior) R&D Ingenieur - Produktentwicklung (m/w/d) - ... AD

Vantive: A New Company Built On Our Legacy Baxter is on a journey to spin off our ~$5B Kidney Care segment into an independent, publicly traded company. Vantive* will build on our nearly 70-year legac...

R&D Engineer - Acute Devices (m/w/d) - ... AD

Vantive: A New Company Built On Our Legacy Baxter is on a journey to separate our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapie...

Lifecycle Management Engineer- Acute Devices (m/w/d) - ... AD

Vantive: A New Company Built On Our Legacy Baxter is on a journey to spin off our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapie...

(Senior) R&D Ingenieur - Produktentwicklung (m/w/d) - ...

Vantive: A New Company Built On Our Legacy Baxter is on a journey to spin off our ~$5B Kidney Care segment into an independent, publicly traded company. Vantive* will build on our nearly 70-year legac...

R&D Engineer - Acute Devices (m/w/d) - ...

Vantive: A New Company Built On Our Legacy Baxter is on a journey to separate our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapie...

Lifecycle Management Engineer- Acute Devices (m/w/d) - ...

Vantive: A New Company Built On Our Legacy Baxter is on a journey to spin off our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapie...

Beauftragter für Umwelt- und Energiemanagement (m/w/d) - ...

Vantive: A New Company Built On Our Legacy Baxter is on a journey to separate our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapie...

Beauftragter für Umwelt- und Energiemanagement (m/w/d) - ... AD

Vantive: A New Company Built On Our Legacy Baxter is on a journey to separate our ~$5B Kidney Care segment into a standalone company. Vantive* will build on our nearly 70-year legacy in acute therapie...